Eric R First

age ~57

from Morristown, NJ

Also known as:
  • Eric Robert First
  • Eric First
  • Eric Frist

Eric First Phones & Addresses

  • Morristown, NJ
  • 52 Street, South Boston, MA 02127
  • 52 North St, South Boston, MA 02127
  • Boston, MA
  • Fort Myers, FL
  • Whitefish Bay, WI
  • Waltham, MA
  • 13 Normandy Blvd W, Morristown, NJ 07960

Isbn (Books And Publications)

Comprehensive Biological Catalysis: A Mechanistic Reference The Lexicon of Terms and Concepts in Mechanistic Enzymology

view source

Author
Eric First

ISBN #
0126468648

Name / Title
Company / Classification
Phones & Addresses
Eric First
Manager
5THSB, LLC
52 N St S, Boston, MA 02127

Us Patents

  • Methods For Treating A Buttock Deformity

    view source
  • US Patent:
    7179474, Feb 20, 2007
  • Filed:
    Sep 3, 2004
  • Appl. No.:
    10/934810
  • Inventors:
    Eric R. First - Boston MA,
  • Assignee:
    Allergan, Inc. - Irvine CA
  • International Classification:
    A61K 39/08
    A61K 39/02
  • US Classification:
    4242391, 424 91, 4242361, 514 2, 514 12, 530350, 530412
  • Abstract:
    Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.
  • Botulinum Toxin Treatment For Kinesia

    view source
  • US Patent:
    20080003242, Jan 3, 2008
  • Filed:
    Aug 9, 2007
  • Appl. No.:
    11/836401
  • Inventors:
    ERIC FIRST - Boston MA,
  • Assignee:
    ALLERGAN, INC. - Irvine CA
  • International Classification:
    A61K 39/08
    A61P 25/00
  • US Classification:
    424239100
  • Abstract:
    Methods for treating kinesia (motion sickness) by local administration of a Clostridial toxin, such as a toxin, to a cranial or neck area of a patient susceptible to motion sickness.
  • Application Of Botulinum Toxin To The Management Of Neurogenic Inflammatory Disorders

    view source
  • US Patent:
    60637684, May 16, 2000
  • Filed:
    Sep 4, 1997
  • Appl. No.:
    8/923884
  • Inventors:
    Eric R. First - South Boston MA
  • International Classification:
    A61K 3800
    A61K 4500
    A61K 4505
  • US Classification:
    514 14
  • Abstract:
    The present invention provides a method for the use of at least one serotype or a combination of serotypes of Botulinum neurotoxin either alone or in combination with other peptides or fusion proteins, that when administered in a safe and effective amount, antagonize and therefore decrease or block inflammation induced by the neurogenic mechanisms underlying or associated with inflammatory disorders, in particular, arthritis.
  • Compositions And Methods For Chemodenervation Using Neurotoxins

    view source
  • US Patent:
    60873272, Jul 11, 2000
  • Filed:
    Jan 30, 1998
  • Appl. No.:
    9/016123
  • Inventors:
    L. Bruce Pearce - Hudson NH
    Eric R. First - Boston MA
  • International Classification:
    A61K 3816
  • US Classification:
    514 2
  • Abstract:
    The compositions and methods disclosed herein utilize admixtures of neurotoxins to cause denervation which is unexpectedly more localized and of longer duration than otherwise occurs with single neurotoxins. The compositions and methods of the invention utilize neurotoxin admixtures calibrated in median paralysis units rather than LD. sub. 50 s. Admixtures of neurotoxins include, but are not limited to, the botulinum serotypes A-G and tetanus toxin. The clinical benefits of the disclosed invention include: lengthening intervals between neurotoxin treatments; reducing adverse immunogenic responses to neurotoxins; and, reducing adverse diffusion-dependent side-effects of neurotoxin treatments.
  • Method And Composition To Improve Absorption Of Therapeutic Agents

    view source
  • US Patent:
    20130122098, May 16, 2013
  • Filed:
    Nov 14, 2011
  • Appl. No.:
    13/373410
  • Inventors:
    Eric R. First - Morristown NJ,
    Ashish B. Patel - West Orange NJ,
    Guido Schmitz - Sparta NJ,
    Stephanie Petaway-Hickson - Morris Plains NJ,
  • Assignee:
    Bayer HealthCare LLC - Morristown NJ
  • International Classification:
    A61K 9/14
    A61P 25/04
    A61K 31/60
    A61P 29/00
    A61K 31/5513
    A61K 31/485
  • US Classification:
    424490, 514221, 514282, 514165
  • Abstract:
    A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling. The blend is then compressed to form tablets that have an enhanced dissolution profile for the medicinally active ingredient.
  • Calcium Supplement

    view source
  • US Patent:
    20120244218, Sep 27, 2012
  • Filed:
    Mar 25, 2011
  • Appl. No.:
    13/065643
  • Inventors:
    Shane E. Durkee - Binningen,
    Pradnya Beke - Morristown NJ,
    Eric R. First - Morristown NJ,
    Ashish B. Patel - West Orange NJ,
  • International Classification:
    A61K 31/194
    A61K 9/28
    A61P 19/10
    A61P 3/02
    A61P 19/08
    A61K 33/10
    A61K 9/52
  • US Classification:
    424457, 424687, 424686, 514574, 424472
  • Abstract:
    An oral dosage form for administration to an animal comprising a biologically utilizable form of calcium and a extended release system that maintains the calcium level in the animal's bloodstream at a substantially beneficial level for a defined period of time.
  • Chewable, Swallowable And Effervescent Solid Dosage Form For Oral Delivery Of Pharmaceutical Actives

    view source
  • US Patent:
    20110300216, Dec 8, 2011
  • Filed:
    Jun 3, 2010
  • Appl. No.:
    12/802275
  • Inventors:
    Eric R. First - Morristown NJ,
    Ashish Bipin Patel - West Orange NJ,
  • International Classification:
    A61K 9/46
    A61P 29/00
    A61K 31/616
  • US Classification:
    424466, 514165
  • Abstract:
    A tablet comprising: (a) an active ingredient; and (b) at least one member of an effervescent couple, wherein said tablet dissolves in water in not more than three minutes and in the mouth in not more than thirty seconds, and wherein said tablet is capable of acting as an effervescent tablet, a rapid-dissolve tablet or a rapidly disintegrating swallow tablet.
  • Botulinum Toxin Therapy For Skin Disorders

    view source
  • US Patent:
    20110206731, Aug 25, 2011
  • Filed:
    Mar 28, 2011
  • Appl. No.:
    13/073741
  • Inventors:
    Eric FIRST - Morristown NJ,
  • Assignee:
    ALLERGAN, INC. - Irvine CA
  • International Classification:
    A61K 39/08
    A61P 17/00
  • US Classification:
    4242391
  • Abstract:
    Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.

Flickr

Classmates

Eric First Photo 4

Eric First

view source
Schools:
Whetstone High School Columbus OH 1996-2000

Googleplus

Eric First Photo 5

Eric First

Facebook

Eric First Photo 6

Eric First

view source
Eric First Photo 7

Eric First

view source
Eric First Photo 8

Eric First

view source
Friends:
Dwi Etika Sari, Susy Maniezt, Firman Sang Iman, Yossi Wae

Get Report for Eric R First from Morristown, NJ, age ~57
Control profile